CDT Equity Inc. (CDT)
NASDAQ: CDT
· Real-Time Price · USD
0.70
-0.01 (-0.71%)
At close: Sep 25, 2025, 3:59 PM
0.70
0.17%
After-hours: Sep 25, 2025, 07:44 PM EDT
Company Description
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets.
The company was founded by David Joszef Tapolczay and Freda C.
Lewis-Hall in October 2021 is headquartered in Naples, FL.
CDT Equity Inc.
| Country | United States |
| IPO Date | Mar 28, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | James Bligh |
Contact Details
Address: 4581 Tamiami Trail North Naples, Florida United States | |
| Website | https://www.conduitpharma.com |
Stock Details
| Ticker Symbol | CDT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000913142 |
| CUSIP Number | 20678X106 |
| ISIN Number | US20678X3044 |
| Employer ID | 36-3601505 |
| SIC Code | 3357 |
Key Executives
| Name | Position |
|---|---|
| Dr. Andrew Regan | Founder, Chief Executive Officer & Director |
| James Bligh | Interim Chief Financial Officer & Director |
| Dr. David Joszef Tapolczay | Head of Strategy & Licensing |
| Dr. Joanne M. Holland | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 22, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| Sep 22, 2025 | 4 | Filing |
| Sep 19, 2025 | 4 | Filing |
| Sep 16, 2025 | 4 | Filing |
| Sep 04, 2025 | 4 | Filing |
| Aug 27, 2025 | 8-K | Current Report |
| Aug 26, 2025 | 4 | Filing |
| Aug 26, 2025 | 4 | Filing |
| Aug 26, 2025 | 4 | Filing |
| Aug 21, 2025 | 4 | Filing |